Eligibility for treatment of hepatitis C virus infection among young injection drug users in 3 US cities.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 16447112.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Among 404 injection drug users aged 18-35 who tested positive for hepatitis C virus (HCV) RNA, 96% had conditions that are potentially unwarranted contraindications for HCV treatment (e.g., problem drinking, moderate-to-severe depression, and recent drug injection). Restrictive eligibility criteria may deny treatment to a large proportion of patients who could benefit from it.
Medical subject headings
- Antiviral Agents
- Hepatitis C
- Patient Selection
- Substance Abuse, Intravenous